ES2159676T3 - Derivados de triazol con actividad antimicotica e intermediarios. - Google Patents

Derivados de triazol con actividad antimicotica e intermediarios.

Info

Publication number
ES2159676T3
ES2159676T3 ES96119900T ES96119900T ES2159676T3 ES 2159676 T3 ES2159676 T3 ES 2159676T3 ES 96119900 T ES96119900 T ES 96119900T ES 96119900 T ES96119900 T ES 96119900T ES 2159676 T3 ES2159676 T3 ES 2159676T3
Authority
ES
Spain
Prior art keywords
antimicotic
intermediate activity
sup
same
triazol derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96119900T
Other languages
English (en)
Inventor
Minoru Tokizawa
Sunao Takeda
Yasushi Kaneko
Hiromichi Eto
Kazuya Ishida
Kazunori Maebashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Application granted granted Critical
Publication of ES2159676T3 publication Critical patent/ES2159676T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)

Abstract

SE DESCRIBE UN DERIVADO TRIAZOL, REPRESENTADO POR LA FORMULA (1), O UNA SAL DEL MISMO, PROCEDIMIENTOS DE PREPARACION DEL MISMO, INTERMEDIARIOS PARA SU PREPARACION, REPRESENTADOS POR LAS FORMULAS (2) Y (3), Y UN COMPUESTO FARMACEUTICO QUE COMPRENDE EL COMPUESTO DE FORMULA (1), O UNA SAL DEL MISMO. DONDE N REPRESENTA 0,1, O 2, X{SUP,1} REPRESENTA H O F, E Y{SUP,1} E Y{SUP,2}, CADA UNO INDEPENDIENTEMENTE, REPRESENTAN H, HALOGENO, O CF{SUB,3}.
ES96119900T 1995-12-22 1996-12-11 Derivados de triazol con actividad antimicotica e intermediarios. Expired - Lifetime ES2159676T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33525195 1995-12-22

Publications (1)

Publication Number Publication Date
ES2159676T3 true ES2159676T3 (es) 2001-10-16

Family

ID=18286437

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96119900T Expired - Lifetime ES2159676T3 (es) 1995-12-22 1996-12-11 Derivados de triazol con actividad antimicotica e intermediarios.

Country Status (8)

Country Link
US (2) US5945438A (es)
EP (1) EP0780380B1 (es)
KR (1) KR100262442B1 (es)
CN (3) CN1058005C (es)
CA (1) CA2193182A1 (es)
DE (1) DE69613328T2 (es)
ES (1) ES2159676T3 (es)
TW (1) TW383299B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438784B (en) * 1997-08-29 2001-06-07 Ssp Co Ltd Triazole derivative or salt thereof and pharmaceutical composition for treating mycosis containing the same
JP3638438B2 (ja) * 1997-12-26 2005-04-13 エスエス製薬株式会社 トリアゾール誘導体またはその塩、その製造方法及び当該化合物を有効成分とする医薬
EP0933368A1 (en) * 1998-02-02 1999-08-04 SSP Co., Ltd. Triazole derivative or salt thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient (antimycotic)
JP2000226368A (ja) 1999-02-04 2000-08-15 Ss Pharmaceut Co Ltd ジフルオロアセトフェノン誘導体の製造法
US6391903B1 (en) * 1999-09-09 2002-05-21 Sankyo Company, Limited Triazole derivatives having antifungal activity
KR20010050557A (ko) 1999-09-29 2001-06-15 타이도 나오카타 아졸 유도체 또는 그의 염
HUP0004741A2 (hu) * 2000-11-28 2002-12-28 Sanofi-Synthelabo Kémiai eljárás tiazolszármazékok előállítására és új intermedier

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0061835B1 (en) * 1981-03-18 1989-02-01 Imperial Chemical Industries Plc Triazole compounds, a process for preparing them, their use as plant fungicides and fungicidal compositions containing them
DK161382C (da) * 1982-04-01 1991-12-09 Pfizer Fremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
BG48681A3 (bg) * 1982-12-14 1991-04-15 Ciba - Geigy Ag Фунгицидно средство
GB8304282D0 (en) * 1983-02-16 1983-03-23 Pfizer Ltd Antifungal agents
DE3461637D1 (en) * 1983-02-16 1987-01-22 Pfizer Ltd Triazole antifungal agents
JPH0383973A (ja) * 1989-08-28 1991-04-09 Sumitomo Pharmaceut Co Ltd エポキシ体のスレオ選択的製造法
CA2031892C (en) * 1989-12-25 2000-08-01 Minoru Tokizawa Triazole derivatives
JP2530253B2 (ja) * 1989-12-25 1996-09-04 エスエス製薬株式会社 トリアゾ―ル誘導体
JPH03284662A (ja) * 1990-03-30 1991-12-16 Asahi Glass Co Ltd α―モノフルオロスルフィド及びその製造方法
JP3471831B2 (ja) * 1991-12-09 2003-12-02 富山化学工業株式会社 新規なトリアゾール誘導体およびその塩

Also Published As

Publication number Publication date
CN1159446A (zh) 1997-09-17
CN1289771A (zh) 2001-04-04
EP0780380B1 (en) 2001-06-13
CN1286248A (zh) 2001-03-07
DE69613328D1 (de) 2001-07-19
DE69613328T2 (de) 2001-09-20
KR100262442B1 (ko) 2000-08-01
HK1011020A1 (en) 1999-07-02
US5986144A (en) 1999-11-16
CA2193182A1 (en) 1997-06-23
TW383299B (en) 2000-03-01
KR970042518A (ko) 1997-07-24
CN1058005C (zh) 2000-11-01
US5945438A (en) 1999-08-31
EP0780380A1 (en) 1997-06-25

Similar Documents

Publication Publication Date Title
ES2072627T3 (es) Derivados de piridina y n-oxido de piridina de diarilmetilpiperidinas o piperazinas, composiciones y uso de las mismas.
ES2145318T3 (es) Imidazo(4,5-c)quinolin-aminas.
ES2175127T3 (es) Derivados de la quinazolina y su uso.
NO884467L (no) Analogifremgangsmaate for fremstilling av aminomethyloxooxazolidinyl-cykloalkylbenzenderivater.
DE69229885D1 (de) Synergistische pestizide Zusammensetzungen
DK166208C (da) Insekticide pyrazolinderivater og fremgangsmaade til fremstilling deraf, middel indeholdende derivaterne samt derivaternes anvendelse til bekaempelse af insekter og spindemider
EP0630898A4 (en) MEDICINE FOR THROMBOZYTOPENIA.
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
NO306930B1 (no) Anvendelse av 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzotiazol (Pramipexol) som et antidepressivt middel
DE69122961D1 (de) Pharmakologische verwendung bestimmter cystinderivate
ATE75743T1 (de) Hydrazinderivate und ihre verwendung.
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
NO923721D0 (no) 4-desoksy-4-epipodophyllotoxin-derivat eller farmasoeytiskakseptabelt salt derav
ES2159676T3 (es) Derivados de triazol con actividad antimicotica e intermediarios.
ES2190471T3 (es) Procedimiento para producir derivados de guanidina, intermedios de dichos compuestos y su produccion.
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
DE69024744D1 (de) Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten
MX9702259A (es) Derivados de quinoxalina utiles en terapia.
DK0621037T3 (da) Pyridopyrimidindioner, fremgangsmåder til deres fremstilling samt deres anvendelse som lægemidler
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
MX9205385A (es) Perhidro-1-h-pirido(1,2-a)piracinas 2-sustituidas neurolepticas.
ES2022896B3 (es) Derivados de azol utiles para el control de enfermedades vegetales.
PT86771A (pt) Process for preparing 4-substituted benzamide derivatives with anticonvulsant activity
DK0454429T3 (da) Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 780380

Country of ref document: ES